# Shuttle Pharmaceuticals Holdings, Inc.: filings

SHPH · Nasdaq · CIK 1757499 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/shph.md) · [Financials](/companies/shph/financials.md) · [Filings](/companies/shph/filings.md) · [Insiders](/companies/shph/insiders.md)

## Reports and events: 147 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 100, 4 27, 3 23, CORRESP 20, UPLOAD 13, 10-Q 12, 424B3 12, S-1/A 11, D 9, S-1 9, EFFECT 8, DEF 14A 7, 10-K 4, ARS 4, DRS/A 4, PRE 14A 4, 5 3, DEFA14A 3, DRS 3, NT 10-Q 3, 424B4 2, 5/A 2, 8-K/A 2, DEF 14C 2, DRSLTR 2, PRE 14C 2, PRER14A 2, SC 13G 2, SCHEDULE 13G/A 2, 10-K/A 1, 10-Q/A 1, 3/A 1, 8-A12B 1, CERT 1, DEFR14A 1, RW 1, S-8 1, SC 13G/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 20:30 ET | [8-K](/filings/0001493152-26-048112.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-26-048112 |
| 2026-09-24 | 16:01 ET | [10-Q](/filings/0001493152-26-044107.md) | Quarterly report, period 2026-06-30 | 0001493152-26-044107 |
| 2026-09-24 | 16:00 ET | [8-K/A](/filings/0001493152-26-044106.md) | 9.01 Financial statements and exhibits | 0001493152-26-044106 |
| 2026-09-16 | 22:15 ET | [8-K](/filings/0001493152-26-042791.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-042791 |
| 2026-09-11 | 11:30 ET | [8-K](/filings/0001493152-26-042299.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-042299 |
| 2026-09-02 | 19:00 ET | [8-K](/filings/0001493152-26-041213.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-041213 |
| 2026-09-01 | 20:05 ET | [8-K](/filings/0001493152-26-041011.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-041011 |
| 2026-08-28 | 20:45 ET | [8-K](/filings/0001493152-26-040622.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-040622 |
| 2026-08-17 | 21:03 ET | [8-K/A](/filings/0001493152-26-038786.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001493152-26-038786 |
| 2026-08-13 | 20:30 ET | [DEF 14A](/filings/0001493152-26-037821.md) | Proxy statement, period 2026-08-13 | 0001493152-26-037821 |
| 2026-07-01 | 23:27 ET | [8-K](/filings/0001493152-26-031375.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-031375 |
| 2026-06-11 | 21:00 ET | [8-K](/filings/0001493152-26-028301.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-028301 |
| 2026-05-27 | 13:00 ET | [8-K](/filings/0001493152-26-025340.md) | 5.07 Shareholder vote results | 0001493152-26-025340 |
| 2026-05-15 | 20:31 ET | [10-Q](/filings/0001493152-26-023859.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023859 |
| 2026-05-07 | 21:20 ET | [8-K](/filings/0001493152-26-021767.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-021767 |
| 2026-05-01 | 13:23 ET | [8-K](/filings/0001493152-26-020830.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-020830 |
| 2026-04-20 | 21:00 ET | [DEF 14A](/filings/0001493152-26-018117.md) | Proxy statement, period 2026-04-20 | 0001493152-26-018117 |
| 2026-03-31 | 20:05 ET | [10-K](/filings/0001493152-26-014131.md) | Annual report, period 2025-12-31 | 0001493152-26-014131 |
| 2026-03-10 | 21:00 ET | [8-K](/filings/0001493152-26-009551.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-009551 |
| 2026-02-17 | 22:20 ET | [8-K](/filings/0001493152-26-007204.md) | 2.02 Results of operations | 0001493152-26-007204 |
| 2026-02-11 | 22:03 ET | [S-1/A](/filings/0001493152-26-006220.md) | Registration statement, amended | 0001493152-26-006220 |
| 2026-02-11 | 02:59 ET | [S-1](/filings/0001493152-26-006073.md) | Registration statement | 0001493152-26-006073 |
| 2026-02-02 | 22:20 ET | [8-K](/filings/0001493152-26-004782.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-004782 |
| 2026-01-12 | 21:16 ET | [8-K](/filings/0001493152-26-001861.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-001861 |
| 2025-12-29 | 21:05 ET | [8-K](/filings/0001493152-25-029361.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-029361 |
| 2025-12-11 | 22:31 ET | [S-1/A](/filings/0001493152-25-027310.md) | Registration statement, amended | 0001493152-25-027310 |
| 2025-11-28 | 22:31 ET | [8-K](/filings/0001493152-25-025430.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-025430 |
| 2025-11-26 | 17:28 ET | [8-K](/filings/0001493152-25-025082.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-025082 |
| 2025-11-21 | 21:05 ET | [8-K](/filings/0001493152-25-024618.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001493152-25-024618 |
| 2025-11-18 | 22:00 ET | [S-1](/filings/0001493152-25-024089.md) | Registration statement | 0001493152-25-024089 |
| 2025-11-17 | 21:05 ET | [8-K](/filings/0001493152-25-023845.md) | 3.01 Delisting notice | 0001493152-25-023845 |
| 2025-11-13 | 15:04 ET | [10-Q](/filings/0001493152-25-022162.md) | Quarterly report, period 2025-09-30 | 0001493152-25-022162 |
| 2025-11-07 | 21:05 ET | [8-K](/filings/0001493152-25-021256.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-021256 |
| 2025-10-21 | 20:05 ET | [8-K](/filings/0001493152-25-018788.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-018788 |
| 2025-09-22 | 21:00 ET | [8-K](/filings/0001493152-25-014489.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-014489 |
| 2025-09-18 | 21:11 ET | [8-K](/filings/0001493152-25-014097.md) | 5.02 Departure or appointment of officers or directors | 0001493152-25-014097 |
| 2025-09-17 | 20:26 ET | [8-K](/filings/0001493152-25-013890.md) | 5.02 Departure or appointment of officers or directors | 0001493152-25-013890 |
| 2025-09-08 | 21:00 ET | [8-K](/filings/0001641172-25-026867.md) | 5.02 Departure or appointment of officers or directors | 0001641172-25-026867 |
| 2025-09-05 | 20:35 ET | [8-K](/filings/0001641172-25-026719.md) | 5.02 Departure or appointment of officers or directors | 0001641172-25-026719 |
| 2025-08-13 | 22:59 ET | [10-Q](/filings/0001641172-25-023263.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023263 |
| 2025-08-05 | 21:51 ET | [S-1](/filings/0001641172-25-022101.md) | Registration statement | 0001641172-25-022101 |
| 2025-07-30 | 21:00 ET | [8-K](/filings/0001641172-25-021566.md) | 5.02 Departure or appointment of officers or directors | 0001641172-25-021566 |
| 2025-06-25 | 13:22 ET | [8-K](/filings/0001641172-25-016394.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-016394 |
| 2025-05-28 | 21:37 ET | [8-K](/filings/0001641172-25-012536.md) | 5.02 Departure or appointment of officers or directors | 0001641172-25-012536 |
| 2025-05-15 | 20:25 ET | [8-K](/filings/0001641172-25-010964.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001641172-25-010964 |
| 2025-05-08 | 21:29 ET | [10-Q](/filings/0001641172-25-009325.md) | Quarterly report, period 2025-03-31 | 0001641172-25-009325 |
| 2025-05-06 | 13:07 ET | [DEF 14A](/filings/0001641172-25-008884.md) | Proxy statement, period 2025-05-06 | 0001641172-25-008884 |
| 2025-04-21 | 20:15 ET | [8-K](/filings/0001641172-25-005553.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-005553 |
| 2025-04-10 | 20:05 ET | [8-K](/filings/0001641172-25-003603.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-003603 |
| 2025-04-04 | 20:10 ET | [8-K](/filings/0001641172-25-002757.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-002757 |

Page 1 of 3. [Older](/companies/shph/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.